New Delhi: In a first, government recognised Centre for Translational Research of Jiwaji University has entered into an industry tie-up to develop new ayurveda-based medicine formulas using nano technology and market new remedies for hitherto incurable diseases.
Taking a cue from successful industry tie-ups of the Council of Scientific and Industrial Research (CSIR) and Defence Research and Development Organisation (DRDO), Madhya Pradesh government-funded Jiwaji University (NAAC A grade accredited) has signed an agreement with Delhi-based AIMIL Pharmaceuticals to study centuries-old ayurvedic formulations, standardise and authenticate them and use information about their potent ingredients for developing new medicines.
“AIMIL will pump in resources, like equipment and technology inputs, to help the university utilise its pool of qualified researchers to its optimal potential,” said AIMIL executive director Sanchit Sharma.
University vice-chancellor Sangita Shukla thanked the Union ayush ministry for promoting research in ayurveda and said, “It is a win-win situation for us. The arrangement will open new avenues for our faculty and students while giving AIMIL access to latest research feedback.”
“Ayurveda is the key to treating some of the incurable diseases. If old formulations are subjected to modern research, we will surely be able to develop world-class medicines with negligible side effects,” said Mr Katoch.